| P50 | author | Kathleen A Worringer | Q47696475 |
| P2093 | author name string | Bill Sugden | |
| | Ajamete Kaykas | |
| P2860 | cites work | A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments | Q74638043 |
| | Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling | Q22253441 |
| | Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases | Q24515076 |
| | Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein | Q24599252 |
| | The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB | Q24646694 |
| | Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module | Q24675538 |
| | Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling | Q28140492 |
| | Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain | Q28142613 |
| | Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation | Q28244717 |
| | TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1 | Q28361340 |
| | Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 |
| | Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression | Q33784729 |
| | Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade | Q33887684 |
| | Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor | Q33888498 |
| | Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins | Q33891012 |
| | A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling | Q33907802 |
| | Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. | Q34250209 |
| | Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus | Q35838888 |
| | Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. | Q36651589 |
| | Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association | Q36695348 |
| | A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. | Q36806077 |
| | Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor | Q38299456 |
| | Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression | Q39593467 |
| | CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex | Q39645275 |
| | Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. | Q39879963 |
| | CD40 signaling in human dendritic cells is initiated within membrane rafts | Q40430095 |
| | Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). | Q41044165 |
| | A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated prot | Q41046589 |
| | The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover | Q41132484 |
| | Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. | Q41429303 |
| | Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40 | Q41700086 |
| | Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses | Q45746898 |
| | Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation | Q45759578 |
| | Receptor-specific induction of individual AP-1 components in B lymphocytes | Q71682510 |
| | Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs | Q73555510 |
| | Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation | Q73731460 |
| | Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement | Q73900277 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transmembrane protein | Q424204 |
| P304 | page(s) | 11551-11560 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling | |
| P478 | volume | 76 | |